1. Behavioral involvement of central dopamine D1 and D2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys;Akai;Jpn. J. Pharmacol.,1995
2. N-0923, a selective dopamine D2 receptor agonist is efficacious in rat and monkey models of Parkinson's disease;Belluzzi;Movement Disord.,1994
3. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns;Proc. Natl. Acad. Sci. USA,1983
4. Molecular biology of the dopamine receptor subtypes;Civelli,1995
5. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine;DaSilva;Synapse,1993